Micafungin plus fluconazole in an infected knee with retained hardware due to candida albicans

Annals of Pharmacotherapy

Volumn 43, Issue 3, 2009, Pages 528-531

  Bland, Christopher M ^a   Thomas, Sanil ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

Albicans; Biofilm; Fluconazole; Joint; Micafungin; Prosthetic

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; FLUCONAZOLE; MICAFUNGIN; POLYETHYLENE; SULTAMICILLIN; VANCOMYCIN;

ADULT; ARTHROCENTESIS; ARTICLE; BACTERIUM CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; COMPUTER; DISEASE EXACERBATION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; JOINT PROSTHESIS; KNEE PAIN; LEUKOCYTE COUNT; MONOTHERAPY; PRIORITY JOURNAL; RANGE OF MOTION; RETAINED INSTRUMENT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; TOTAL KNEE REPLACEMENT; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BIOFILMS; CANDIDIASIS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; FEMALE; FLUCONAZOLE; HUMANS; KNEE PROSTHESIS; LIPOPEPTIDES; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS;

EID: 62949219912     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L508     Document Type: Article

References (17)

1. Darouiche RO, Hamill RJ, Musher DM, Young EJ, Harris RL. Periprosthetic candidal infections following arthroplasty. Rev Infect Dis 1989;11: 89-96.
2. Petraitis V, Petraitiene R, Sarafandi AA, et al. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin. J Infect Dis 2003;187:1834-43.
3. Cateau E, Rodier MH, Imbert C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J Antimicrob Chemother 2008;62:153-5.
4. Crum N, Lederman E, Wallace M. Infections associated with tumor necrosis factor-alpha antagonists. Medicine 2005;84:291-302.
5. Product information. Arava (leflunomide). Bridgewater, NJ: Sanofi-Aventis US, July 2007.
6. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46:1773-80.
7. Adam B, Baillie GS, Douglas LJ. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 2002;51:344-9.
8. Katragkou A, Chatzimoschou A, Simitsopoulou M.et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 2008;52:357-60.
9. Ernst E, Klepser ME, Pfaller MA. Postantifungal effects of echinocan- din, azole, and polyene antifungal agents against Candida albicans and Cryplococcus neoformans. Antimicrob Agents Chemother 2000;44: 1108-11.
10. Baillie GS, Doublas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000;46:397- 403.
11. Phelan DM, Osmon DR, Keating MR, Hanssen AD. Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of literature. Clin Infect Dis 2002;34:930-8.
12. Dumaine V, Eyrolle L, Baixench MT, et al. Successful treatment of prosthetic knee Candida glabrata infection with caspofungin combined with flucytosine. Int J Antimicrob Agents 2008;31:398-9.
13. Cappelletty D, Eiselstein-McKitrick K. The echinocandins. Pharmacotherapy 2007;27:369-88.
14. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albican biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002;46:3643-6.
15. Lejko-Zupanc T, Mozina E, Vrevc F. Caspofungin as treatment for Candida glabrata hip infection. Int J Antimicrob Agents 2005;25:273-4.
16. Bennett JE, Dismukes WE, Haywood M, Duma R, Medoff G. A comparison of amphotericin B alone and in combination with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979;301:126-31.
17. Karlowsky JA, Hoban DJ, Zhanel GG, Goldstein BP. In vitro interactions with anidulafungin with azole antifungals, amphotericin B, and 5- fluorocytosine against Candida species. Int J Antimicrob Agents 2006; 27:174-7.